Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Clinical trial NCT05203562 · UNKNOWN

Trial details

NCT number: NCT05203562
Sponsor: Zagazig University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Gestational Trophoblastic Disease

Start date: 2020-06-01
Primary completion: 2022-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.